Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial.
Lim SCL, Hor CP, Tay KH, Mat Jelani A, Tan WH, Ker HB, Chow TS, Zaid M, Cheah WK, Lim HH, Khalid KE, Cheng JT, Mohd Unit H, An N, Nasruddin AB, Low LL, Khoo SWR, Loh JH, Zaidan NZ, Ab Wahab S, Song LH, Koh HM, King TL, Lai NM, Chidambaram SK, Peariasamy KM; I-TECH Study Group. Lim SCL, et al. JAMA Intern Med. 2022 Apr 1;182(4):426-435. doi: 10.1001/jamainternmed.2022.0189. JAMA Intern Med. 2022. PMID: 35179551 Free PMC article. Clinical Trial.
Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study.
Low EV, Pathmanathan MD, Chidambaram SK, Kim WR, Lee WJ, Teh ZW, Appannan MR, Zin SM, Zin FM, Amin SBM, Ismail M, Samad AA, Peariasamy KM. Low EV, et al. Int J Infect Dis. 2023 Oct;135:77-83. doi: 10.1016/j.ijid.2023.08.003. Epub 2023 Aug 9. Int J Infect Dis. 2023. PMID: 37567557 Free article.
Economic Evaluation of Nirmatrelvir/Ritonavir Among Adults Against Hospitalization During the Omicron Dominated Period in Malaysia: A Real-World Evidence Perspective.
Low EV, Teh HS, Hing NYL, Chidambaram SK, Pathmanathan MD, Kim WR, Lee WJ, Teh ZW, Appannan MR, Zin SM, Zin FM, Amin SBM, Ismail M, Samad AA, M Peariasamy K. Low EV, et al. Drugs Real World Outcomes. 2024 Jun;11(2):299-308. doi: 10.1007/s40801-024-00427-0. Epub 2024 May 10. Drugs Real World Outcomes. 2024. PMID: 38727886 Free PMC article.
Trends in medicine utilisation in public and private healthcare facilities before and during COVID-19: a nationwide analysis of medicine procurement and sales data, 2018-2022.
Ab Rahman N, Low EV, Lim AH, Ahmad Shanizza AI, Ho SW, Kamal M, Mohamad Yahaya AH, Sivasampu S. Ab Rahman N, et al. Among authors: low ev. J Pharm Policy Pract. 2024 Sep 25;17(1):2401468. doi: 10.1080/20523211.2024.2401468. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39328842 Free PMC article.
Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study.
Lee KY, Wan Ahmad WA, Low EV, Liau SY, Anchah L, Hamzah S, Liew HB, Mohd Ali RB, Ismail O, Ong TK, Said MA, Dahlui M. Lee KY, et al. Among authors: low ev. PLoS One. 2017 Sep 5;12(9):e0184410. doi: 10.1371/journal.pone.0184410. eCollection 2017. PLoS One. 2017. PMID: 28873473 Free PMC article.
14 results